Jutkowitz Eric, Bynum Julie P W, Mitchell Susan L, Cocoros Noelle M, Shapira Oren, Haynes Kevin, Nair Vinit P, McMahill-Walraven Cheryl N, Platt Richard, McCarthy Ellen P
Department of Health Services Policy & Practice Brown University School of Public Health Providence Rhode Island 02912 USA.
Providence Veterans Affairs (VA) Medical Center Center of Innovation in Long Term Services and Supports Providence Rhode Island 02908 USA.
Alzheimers Dement (Amst). 2020 Jul 5;12(1):e12048. doi: 10.1002/dad2.12048. eCollection 2020.
One-third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD-related dementias (AD/ADRD).
We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date.
In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post-index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts.
The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee-for-service.
三分之一的医疗保险受益人参加了医疗保险优势计划(MA)。然而,对于被诊断患有阿尔茨海默病(AD)和AD相关痴呆症(AD/ADRD)的MA受益人,我们知之甚少。
我们计算了2014年和2016年三个MA计划中AD/ADRD诊断的患病率。我们确定了被诊断患有AD/ADRD的受益人的人口统计学特征,以及他们在索引日期后的364天内是否因任何原因退出MA计划。
2014年和2016年,AD/ADRD诊断的总体患病率分别为5.6%和6.5%。2016年,AD/ADRD受益人平均年龄为82.4岁(标准差=7.4),女性占61.8%,且有多种合并症。到索引日期后364天,32%的AD/ADRD受益人已退出其计划。2014年被诊断患有AD/ADRD的受益人的人口统计学特征与2016年的类似。
MA中AD/ADRD诊断的患病率低于医疗保险按服务收费报告的比率。